Formation of copper oxychloride and reactive oxygen species as causes of uterine injury during copper oxidation of Cu-IUD

Contraception

Volumn 61, Issue 2, 2000, Pages 99-103

  Beltran Garcia, Miguel J ^a   Espinosa, Adriana ^a   Herrera, Norma ^b   Perez Zapata, Aura J ^a   Beltran Garcia, Celia ^c   Ogura, Tetsuya ^b  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b Hospital General de Atizapan   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE GUADALAJARA   (Mexico)

Author keywords

Copper; Copper oxychloride; Cytotoxicity; IUD; Reactive oxygen species; Uterine injuries

Indexed keywords

CATALASE; COPPER DERIVATIVE; COPPER INTRAUTERINE DEVICE; COPPER ION; COPPER OXYCHLORIDE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; UNCLASSIFIED DRUG;

AMNION CELL; ARTICLE; CELL DEATH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTRACEPTION; CYTOTOXICITY; ENDOMETRIUM; HUMAN; HUMAN CELL; INTRAUTERINE CONTRACEPTIVE DEVICE; OXIDATION; PATHOGENESIS; UTERINE CERVIX DISEASE; UTERUS DISEASE;

AMERICAS; BIOLOGY; CERVICAL EFFECTS; CERVIX; CLINICAL RESEARCH; CONTRACEPTION; CONTRACEPTIVE METHODS; DEVELOPED COUNTRIES; FAMILY PLANNING; GENITALIA; GENITALIA, FEMALE; IUD; IUD, COPPER RELEASING; NORTH AMERICA; NORTHERN AMERICA; PHYSIOLOGY; RESEARCH METHODOLOGY; RESEARCH REPORT; TOXICITY; UNITED STATES; UROGENITAL SYSTEM; UTERINE EFFECTS; UTERUS;

CATALASE; CELL LINE; CELL SURVIVAL; CONTRACEPTION; COPPER; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYDROXYL RADICAL; INTRAUTERINE DEVICES, COPPER; NEUTRAL RED; OXIDATION-REDUCTION; THIOBARBITURIC ACID REACTIVE SUBSTANCES; UTERINE DISEASES; UTERUS;

EID: 0034063831     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(00)00085-8     Document Type: Article

References (41)

1. Kimble-Haas SL. The intrauterine device: dispelling the myths. Nurse Pract 1998;23:58,63,66-9,73.
2. Toder V., Madanes A., Gleicher N. Immunologic aspects of IUD action. Contraception. 37:1988;391-403.
3. Shimizu K., Nishikawa T., Nozaki M., Oshima K. Effects of an intrauterine copper device on serum copper, endometrial histology, and ovarian, hepatic and renal functions in the Japanese monkey (Macaca fuscata fuscata). J Med Primatol. 20:1991;277-283.
4. Yin M., Zhu P., Luo H., Xu R. The presence of mast cells in the human endometrium pre- and post-insertion of intrauterine device. Contraception. 48:1993;245-254.
5. Kaplan B., Orvieto R., Hirsch M., et al. The impact of intrauterine contraceptive devices on cytological findings from routine Pap smears testing. Eur J Reprod Health Care. 3:1998;75-77.
6. Kjaer A., Laursen K., Thormann L., Borggard O., Lebech P.E. Copper released from copper intrauterine devices removed after up to 8 years of use. Contraception. 47:1993;349-358.
7. Roblero L., Guadarrama A., Lopez T. Effect of copper ion on the motility, viability, acrosome reaction and fertilizing capacity of human spermatozoa in vitro. Reprod Fertil Develop. 8:1996;871-874.
8. Ortiz M.E., Coxatto H.B., Bardin C.W. Mechanism of action of intrauterine devices. Obstet Gynecol Surv. 51:1996;S42-S51.
9. Fortney J.A., Feldblum P.J., Raymond E.G. Intrauterine devices - the optimal long-term contraceptive method? J Reprod Med. 44:1999;269-274.
10. Burkman R.T. Intrauterine devices and pelvic inflammatory disease evolving perspectives on the data . Obstet Gynecol Surv. 51:1996;S35-S41.
11. Pasquale S. Clinical experience with today's IUDs. Obstet Gynecol Surv. 51:1996;S25-S29.
12. Mossa B., Marziani R., Galeano C., Magnanti G., Domenici R. Epidemiologic study of cervico-vaginal pathology in IUD users. Minerva Ginecol. 45:1993;27-30.
13. Kobayashi T.K., Casslen B., Stormby N. Cytologic atypias in the uterine fluid of intrauterine contraceptive device users. Acta Cytol. 27:1983;138-141.
14. Misra J.S., Engineer A.D., Das K., Tandon P. Cervical carcinogenesis and contraception. Diagn Cytopathol. 7:1991;346-352.
15. Barceloux D.G. Copper. Clin Toxicol. 37:1999;217-230.
16. Amla S., Gupta I., Ganguly N.K. Active oxygen species in copper intrauterine device users. Contraception. 48:1993;150-156.
17. Gupta I., Kaushalya S., Gupta K.R., Mahajan U., Prasad R., Ganguly N.K. Copper levels and reactive oxygen species in uterine flushings in copper intrauterine contraceptive device users. Indian J Med Res. 100:1994;225-227.
18. Pradhan M., Gupta I., Ganguly N.K. Nitrites and L-citrulline levels in copper intrauterine device users. Contraception. 55:1997;315-318.
19. Gupta A.I., Gupta S.K., Ganguly N.K. Reactive oxygen intermediate and reactive nitrogen intermediates in copper intrauterine device users. Contraception. 59:1999;67-70.
20. Clopton D.A., Saltman P. Copper-specific damage in human erythrocyte exposed to oxidative stress. Biol Trace Elem. Res. 56:1997;231-240.
21. Ueda J., Takai M., Shimazu Y., Ozawa T. Reactive oxygen species generated from the reaction of copper (II) complexes with biological reductans cause DNA strand scission. Arch Biochem Biophys. 357:1998;231-239.
22. Hayashi A., Ryu A., Suzuki T., Kawada A., Tajima S. In vitro degradation of tropoelastin by reactive oxygen species. Arch Dermatol Res. 290:1998;497-500.
23. Kocha T., Yamaguchi M., Ohtaki T., Fukuda T., Aoyagi T. Hydrogen peroxide mediated degradation of protein different oxidation modes of copper and iron dependent hydroxyl radicals on the degradation of albumin . Biochim Biophys Acta. 1337:1997;319-326.
24. Babich H., Borenfreud E. Neutral red assay for toxicology in vitro. Watson R.R. In Vitro Methods for Toxicology. 1992;237-248 CRC Press, Boca Raton, FL.
25. Rice E.C., Symons M.R.C. Techniques in free radical research. Burdon R.H., van Knippenberg P.H. Biochemsitry and Molecular Biology Series. 1991;51-76 Elsevier, New York.
26. Chertithin G.V., Lester A., Bauschlicher C.W. Jr. Reactions of laser-ablated copper atoms with dioxygen. Infrared spectra of the copper oxides CuO, OCuO, CuOCuO, and OCuOCuO and superoxide CuOO in solid argon. J Phys Chem A. 101:1997;4026-4034.
27. Gunther M.R., Hanna P.M., Mason R.P., Cohen M.S. Hydroxyl radical formation from cuprous ion and hydrogen peroxide a spin trapping study . Arch Biochem Biophys. 316:1995;515-522.
28. Feitknecht W. Zur Chemie und Morphologie der basischen Salze zweiwertiger Metalle. Helv Chim Acta. 32:1949;1639-1653.
29. Dirkse T.P. Copper, silver, gold and zinc, cadmium, mercury oxide and hydroxides. Kertes A.S. Solubility Data Series. 23:1986;10-82 Pergamon, Oxford.
30. Bumgardner J.D., Johansson B.I. Galvanic corrosion and cytotoxic effect of amalgam and gallium alloys coupled to titanium. Eur J Oral Sci. 104:1996;300-308.
31. Lapointe S., Sullivan R., Sirard M.A. Binding of a bovine oviductal fluid catalase to mammalian spermatozoa. Biol Reprod. 58:1998;747-753.
32. Misra J.S., Engineer A.D., Tandon P. Cytopathological change in human cervix and endometrium following prolonged retention of copper ion bearing intrauterine contraceptive device. Diagn Cytopathol. 5:1989;237-242.
33. Gonzalez-Angulo A., Aznar-Ramos R. Ultrastructural studies on the endometrium of women wearing TCu-200 intrauterine devices by means of transmission and scanning electron microscopy and x-ray dispersive analysis. Am J Obstet Gynecol. 125:1976;170-179.
34. Mizumoto H., Hohman W.R., Moyer D.L. Effects of intrauterine devices on nuclear deoxyribonucleic acid metabolism in rabbit blastocysts an autoradiographic study . Fertil Steril. 27:1976;449-458.
35. Tobert J.A., Davies D.R. Effect of copper and platinum intrauterine devices on endometrial morphology and implantation in the rabbit. J Reprod Fertil. 50:1977;53-59.
36. Parazzini F., La Vecchia C., Negri E. Use of intrauterine device and risk of invasive cervical cancer. Int J Epidemiol. 21:1992;1030-1031.
37. Amla S., Gupta I., Kausalya S., Ganguly N.K. Active oxygen species in copper intrauterine device users. Contraception. 48:1993;150-156.
38. Lassise D.L., Savitz D.A., Hamman R.F., Baron A.E., Brinton L.A., Levines R.S. Invasive cervical cancer and intrauterine device use. Int J Epidemiol. 20:1991;865-870.
39. Castellsague X., Thompson W.D., Dubrow R. Intra-uterine contraception and the risk of endometrial cancer. Int J Cancer. 54:1993;911-916.
40. Kohler U., Wuttke P. Ergebnisse einer Fall-Kontroll-Studie zum aktuellen Einfluss verschiedener Faktoren auf das Zervixkarzinomrisiko. 2. Mitteilung Kontrazeptionsverhalten und Faktor Rauchen . Zentral Gynakol. 116:1994;405-409.
41. Parazzini F., La Vecchia C., Moroni S. Intrauterine device use and risk of endometrial cancer. Br J Cancer. 70:1994;672-673.